SCHEMBL7326549

SCHEMBL7326549

CCC(=O)NC1CCc2c(cccc2NC(C)=O)C1

nearest known ligand 0.62

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 10/20 0.62
MTNR1B P49286 10/20 0.62
CYP1A2 P05177 1/20 0.57
MAPT P10636 1/20 0.57
CYP2C9 P11712 1/20 0.57
ALOX15 P16050 1/20 0.57
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
ACHE P22303 2/20 0.48
ALDH1A1 P00352 2/20 0.45
MEN1 O00255 1/20 0.44
LMNA P02545 1/20 0.44
THRA P10827 1/20 0.44
THRB P10828 1/20 0.44
KMT2A Q03164 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7324893 0.93 MTNR1A (0.65) MTNR1AMTNR1BCYP1A2MAPTCYP2C9
SCHEMBL7335952 0.88 MTNR1A (0.60) MTNR1AMTNR1BCYP1A2MAPTCYP2C9
SCHEMBL7336034 0.85 DRD2 (0.57) MTNR1AMTNR1BCA1CA2ACHE
Hydrochloric Acid SCHEMBL7334747 0.84 DRD2 (0.56) MTNR1AMTNR1BCA1CA2ACHE
SCHEMBL7328332 0.83 DRD2 (0.55) MTNR1AMTNR1BCA1CA2ACHE
SCHEMBL7328237 0.83 DRD2 (0.65) MTNR1AMTNR1BALDH1A1MEN1LMNA
Hydrochloric Acid SCHEMBL7333108 0.82 DRD2 (0.53) MTNR1AMTNR1BCA1CA2ACHE
Hydrochloric Acid SCHEMBL7329618 0.82 DRD2 (0.64) MTNR1AMTNR1BALDH1A1MEN1LMNA
SCHEMBL7331004 0.81 MTNR1A (0.60) MTNR1AMTNR1BCYP1A2MAPTCYP2C9
SCHEMBL7333316 0.81 MTNR1A (0.67) MTNR1AMTNR1BCYP1A2MAPTCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5196454-A METHOD OF TREATING DISORDERS OF THE DOPAMINERGIC SYSTEMS USING 2,5-DIAMINOTETRALINES BOEHRINGER INGELHEIM KG (DE) 1993-03-23 US disclosed
EP-0402923-A2 2,5-Diaminotetralines, process for their preparation and their use as medicine BOEHRINGER INGELHEIM KG (DE) 1990-12-19 EP disclosed